AU672679B2 - Substituted mono- and bipyridylmethylpyridones - Google Patents

Substituted mono- and bipyridylmethylpyridones Download PDF

Info

Publication number
AU672679B2
AU672679B2 AU60561/94A AU6056194A AU672679B2 AU 672679 B2 AU672679 B2 AU 672679B2 AU 60561/94 A AU60561/94 A AU 60561/94A AU 6056194 A AU6056194 A AU 6056194A AU 672679 B2 AU672679 B2 AU 672679B2
Authority
AU
Australia
Prior art keywords
chain
carbon atoms
straight
represent
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60561/94A
Other languages
English (en)
Other versions
AU6056194A (en
Inventor
Martin Beuck
Hilmar Bischoff
Dirk Denzer
Jurgen Dressel
Peter Fey
Rudolf Hanko
Walter Hubsch
Stanislav Kazda
Andreas Knorr
Thomas Kramer
Ulrich Muller
Matthias Muller-Gliemann
Johannes-Peter Stasch
Stefan Wohlfeil
Siegfried Zaiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU6056194A publication Critical patent/AU6056194A/en
Application granted granted Critical
Publication of AU672679B2 publication Critical patent/AU672679B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU60561/94A 1993-05-13 1994-04-19 Substituted mono- and bipyridylmethylpyridones Ceased AU672679B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4316077 1993-05-13
DE4316077A DE4316077A1 (de) 1993-05-13 1993-05-13 Substituierte Mono- und Bihydridylmethylpyridone

Publications (2)

Publication Number Publication Date
AU6056194A AU6056194A (en) 1994-11-17
AU672679B2 true AU672679B2 (en) 1996-10-10

Family

ID=6488035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60561/94A Ceased AU672679B2 (en) 1993-05-13 1994-04-19 Substituted mono- and bipyridylmethylpyridones

Country Status (21)

Country Link
US (1) US5407948A (enExample)
EP (1) EP0624583B1 (enExample)
JP (1) JPH06329669A (enExample)
CN (1) CN1102648A (enExample)
AT (1) ATE155782T1 (enExample)
AU (1) AU672679B2 (enExample)
CA (1) CA2123243A1 (enExample)
CZ (1) CZ117294A3 (enExample)
DE (2) DE4316077A1 (enExample)
DK (1) DK0624583T3 (enExample)
ES (1) ES2105408T3 (enExample)
FI (1) FI942160A7 (enExample)
GR (1) GR3024465T3 (enExample)
HU (1) HUT70485A (enExample)
IL (1) IL109604A0 (enExample)
NO (1) NO941770L (enExample)
NZ (1) NZ260490A (enExample)
PH (1) PH30908A (enExample)
SK (1) SK55694A3 (enExample)
TW (1) TW245718B (enExample)
ZA (1) ZA943246B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
US7998986B2 (en) 2001-12-21 2011-08-16 Exelixis Patent Company Llc Modulators of LXR
AP1822A (en) * 2002-02-14 2008-01-30 Pharmacia Corp Substituted pyridinones as modulators of P38 MAP kinase.
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
AU2006285038A1 (en) * 2005-08-29 2007-03-08 Vertex Pharmaceuticals Incorporated 3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases
JP5112317B2 (ja) * 2005-08-29 2013-01-09 バーテックス ファーマシューティカルズ インコーポレイテッド 非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
WO2007027729A1 (en) 2005-08-29 2007-03-08 Vertex Pharmaceuticals Incorporated 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
BRPI0816970A2 (pt) * 2007-09-14 2015-03-24 Ortho Mcneil Janssen Pharm 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
EA017648B1 (ru) * 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
CA2704436C (en) * 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
CA2774039A1 (en) * 2009-11-06 2011-05-12 Aerpio Therapeutics Inc. Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Ｇｐｒ８４アンタゴニストおよびその使用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100917A0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
US5155117A (en) * 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines

Also Published As

Publication number Publication date
DE4316077A1 (de) 1994-11-17
HUT70485A (en) 1995-10-30
CN1102648A (zh) 1995-05-17
GR3024465T3 (en) 1997-11-28
ZA943246B (en) 1995-01-18
JPH06329669A (ja) 1994-11-29
HU9401417D0 (en) 1994-08-29
FI942160L (fi) 1994-11-14
SK55694A3 (en) 1995-02-08
CA2123243A1 (en) 1994-11-14
ATE155782T1 (de) 1997-08-15
NZ260490A (en) 1995-12-21
EP0624583A1 (de) 1994-11-17
US5407948A (en) 1995-04-18
AU6056194A (en) 1994-11-17
IL109604A0 (en) 1994-08-26
EP0624583B1 (de) 1997-07-23
CZ117294A3 (en) 1994-11-16
NO941770L (no) 1994-11-14
PH30908A (en) 1997-12-23
TW245718B (enExample) 1995-04-21
FI942160A0 (fi) 1994-05-10
NO941770D0 (no) 1994-05-11
DK0624583T3 (da) 1998-03-02
FI942160A7 (fi) 1994-11-14
ES2105408T3 (es) 1997-10-16
DE59403427D1 (de) 1997-08-28

Similar Documents

Publication Publication Date Title
US5407948A (en) Substituted mono- and bipyridylmethylpyridones
US5254543A (en) Sulphonylbenzyl-substituted pyridones which are angiotension II receptor antagonists
US5354749A (en) Sulfonylbenzyl-substituted benzo- and pyridopyridones
DE4221583A1 (de) Substituierte biphenylpyridone
EP0569013A1 (en) Quinoline compounds as angiotensin II antagonists
IE920020A1 (en) Azole derivatives, process for their preparation, and their¹use
PT611767E (pt) Derivados de acido fenil-ciclo-hexano-carboxilico heterociclicamente substituidos
US5587390A (en) Imidazole derivatives having a II antagonist activity
CZ297692A3 (en) Substituted derivatives of imidazolyl-propenoic acid
CZ29793A3 (en) Phenylacetic acid substituted amides
US5407942A (en) Biphenylmethyl-substituted pyridones
CZ297792A3 (en) Cyclically substituted derivatives of imidazolyl-propenoic acid
US5594010A (en) Substituted monopyridylmethyl derivatives
AU670487B2 (en) Heterotricyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
IL101014A (en) 4-pyrimidinone derivatives their preparation and pharmaceutical compositions containing them
US5492923A (en) Substituted pyridines and 2-oxo-1,2-dihydropyridines
US5376671A (en) Propenoyl-imidazole derivatives
WO1994011365A1 (en) Substituted benzimidazoles and quinazolines as antihypertensives
US5414003A (en) Pyridinylmethyl-substituted pyridines and pyridones
AU666222B2 (en) Alkoxymethyl-substituted pyridonebiphenyls
AU666732B2 (en) Imidazolyl-substituted cyclohexane derivatives
US5576342A (en) Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
CZ71094A3 (en) Phenylglycinamides of heterocyclically substituted derivatives of phenylacetic acid, process of their preparation, medicaments in which said derivatives are comprised, process of their preparation and use
CZ15993A3 (en) Sulfonylbenzyl-substituted derivatives of imidazolylpropenoic acid
US5530016A (en) Substituted 2,4-imidazolidinediones